DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Turpie A, Bauer K, Davidson B. et al.
Comparison of rivaroxaban – an oral, direct factor Xa inhibitor – and subcutaneous enoxaparin for thromboprophylaxis after total knee replacement (RECORD4: a phase 3 study).
European Federation of National Associations of Orthopaedics and Traumatology (EFFORT) 2008 Annual Meeting; May 29–June 1,.
2008 Nice, France. Abstract F85.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.